Filing Details
- Accession Number:
- 0001415889-22-002663
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-07 17:00:22
- Reporting Period:
- 2022-03-03
- Accepted Time:
- 2022-03-07 17:00:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591312 | I Bassil Dahiyat | C/O Xencor, Inc. 111 W. Lemon Ave Monrovia CA 91016 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-03-03 | 2,929 | $29.90 | 160,548 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-03-03 | 49,761 | $0.00 | 210,309 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | A | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Acquisiton | 2022-03-03 | 298,567 | $0.00 | 298,567 | $30.02 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
298,567 | 2032-03-02 | No | 4 | A | Direct |
Footnotes
- Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 7,868 restricted stock units.
- The weighted average sale price for the transaction reported was $29.9013, and the range of prices were between $29.86 and $29.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- Includes the following shares acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan: 196 shares acquired in June 2021 and 218 shares acquired in December 2021.
- Represents restricted stock units that vest as follows: 1/3 of the shares vest on the first, second and third anniversaries of the date of grant.
- 25% of the shares subject to the option shall vest on the one year anniversary of March 3, 2022 (the "Vesting Commencement Date") and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.